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Summary
Objective: The investigation of the expression and localization of connective tissue growth factor/hypertrophic chondrocyte-speciﬁc gene
product 24/CCN family member 2 (CTGF/Hcs24/CCN2) in normal and osteoarthritic (OA) cartilage, and quantiﬁcation of CTGF/Hcs24-positive
cells.
Methods: Cartilage samples of patients (n ¼ 20) with late stage OA were obtained at total joint replacement surgery. Morphologically normal
cartilage was harvested for comparison purposes from the femoral heads of 6 other patients with femoral neck fracture. Parafﬁn-embedded
sections were stained by Safranin O. The severity of the OA lesions was divided into four stages (normal, early, moderate, and severe). The
localization of protein and mRNA for CTGF/Hcs24 was investigated by immunohistochemistry and in situ hybridization, respectively. The
population of CTGF/Hcs24-positive chondrocytes in OA cartilage and chondro-osteophyte was quantiﬁed by counting the number of the cells
under light microscopy.
Results: Signals for CTGF/Hcs24 were detected in a small percentage of chondrocytes throughout the layers of normal cartilage. In early
stage OA cartilage, the CTGF/Hcs24-positive chondrocytes were localized mainly in the superﬁcial layer. In moderate to severe OA cartilage,
intense staining for CTGF/Hcs24 was observed in proliferating chondrocytes forming cell clusters next to the cartilage surface. In chondro-
osteophyte, strong signals were found in the chondrocytes of the proliferative and hypertrophic zones.
Conclusion: CTGF/Hcs24 expression was detected in both normal and OA chondrocytes of human samples. The results of the current study
suggested that expression of CTGF/Hcs24 was concomitant with development of OA lesions and chondrocyte differentiation in chondro-
osteophyte.
 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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SocietyIntroduction
Osteoarthritis (OA) is a proliferative joint disease charac-
terized by articular cartilage degeneration, osteophyte
formation, subchondral bone sclerosis, and secondary
induced synovitis1. In the course of development of OA,
there is an imbalance between cartilage degeneration and
attempts to repair as seen in chondrocyte cloning, covering
of ﬁbrous tissue over the cartilage, and marginal osteophyte
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relative concentration of growth factors and cytokines, or
altered response of chondrocytes might determine the rate
of progression of this disease3. Mature chondrocytes and
their precursors produce and respond to a wide range of
growth factors4, such as ﬁbroblast growth factors (FGF)5,6,
epidermal growth factors (EGF)7,8, insulin-like growth
factors (IGF)8,9, transforming growth factors (TGF)6,10,
and bone morphogenic proteins (BMP)11e13. We previously
cloned by the differential display PCR method14 an mRNA
predominantly expressed in hypertrophic chondrocytes
from a newly established immortal, clonal chondrocytic cell
line (HCS-2/8)15e19. Its gene product, named hypertrophic
chondrocyte-speciﬁc gene product 24(Hcs24), was identical
with connective tissue growth factor (CTGF)20e23, which
is a member of the so called ‘‘connective tissue growth
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(CCN) family’’20. CTGF/Hcs24 is induced by growth factors
such as TGF-b, and regulates cell proliferation, migration,
angiogenesis, and wound healing20,24. We also reported
that CTGF/Hcs24 speciﬁc receptors were present
on chondrocytic cells25 and recombinant CTGF/Hcs24
promoted proliferation and differentiation of chondrocytes
in vitro26. Moreover, CTGF/Hcs24 has a role in the pro-
liferation, migration and tube formation of vascular endo-
thelial cells in vitro and angiogenesis in vivo27,28. Although
recent reports suggested that CTGF/Hcs24 is expressed in
normal and OA chondrocytes11,29, the precise localization
and relationship with cartilage degeneration has not been
fully understood.
In the current study, we examined the expression and
localization of CTGF/Hcs24 in normal and different stages
of OA cartilage lesions and in chondro-osteophyte at the
mRNA and protein levels by in situ hybridization and
immunohistochemistry, respectively.
Materials and methods
PATIENT SELECTION AND TISSUE PREPARATION
Human OA cartilage was obtained at the time of total joint
replacement surgery (10 hips and 10 knees) from 18 OA
patients (2 males and 16 females, aged 43e78 years, mean
66.8 years) who lacked indication of other inﬂammatory
diseases. All the cases satisﬁed the American College of
Rheumatology criteria for OA of the hip and knee.
Comparison samples of macroscopically normal cartilage
were obtained from the resected femoral heads of 6
patients with femoral neck fracture. Informed consent was
obtained from all the patients. The chondro-osteophyte
samples were also obtained from the 15 samples from the
different series of OA patients previously described30. The
samples were immediately ﬁxed in 4% paraformaldehyde in
0.1 M phosphate buffered saline (PBS), decalciﬁed in 0.3 M
EDTA ( pH 7.5) for 2e3 weeks, and embedded in parafﬁn.
Three sections from each sample were used for the
histological and immunohistochemical studies, and 5
sections from 5 OA samples were used for in situ
hybridization analysis.
HISTOLOGICAL EVALUATION OF OA SEVERITY
All sections were stained with Safranin O and observed
by light microscopy. Histological classiﬁcation of the
severity of OA lesions was graded on a scale of 0e13,
using the modiﬁed Mankin score reported by van der Sluijs
et al.31, a combined score assessing structure; (0e6
points), cellular abnormalities; (0e3 points), and matrix-
staining (0e4 points). As a result, 0 points represent normal
and 13 points represent the most severe cartilage lesions.
The modiﬁed Mankin score point-range of 14 points was
divided into 4 ranges in the current study: normal (0 point),
early OA (1e3 points), moderate OA (4e8 points), and
severe OA (9e13 points).
IMMUNOHISTOCHEMICAL STAINING
The parafﬁn sections were soaked in xylene to remove
parafﬁn, then dehydrated in a graded alcohol series
(50e100%). Antigen retrieval was performed by autoclaving
for 15 min at 121(C. Additional enzymic digestion by
testicular hyaluronidase (1.0 mg/ml, 37(C for 3 h) forepitope unmasking did not affect the stainability of CTGF/
Hcs24 (data not shown). After cooling, endogenous
peroxidase activity was quenched with 0.3% H2O2 in PBS.
Anti-CTGF/Hcs24 antibodies were raised in the rabbit by
immunization with a synthetic peptide of CTGF/Hcs24
composed of 20 amino acids (240e259: RPCEADLEENI-
KKGKKCIRT), the sequence of which was the same as that
of Fisp12 (the mouse homolog of CTGF), but not the same
as that of Cyr61, Nov, WISP-1/Elm-1, WISP-2/rCop-1/
CTGF-3, or WISP-3. Using Western blotting techniques,
we previously conﬁrmed that the synthetic peptide of CTGF/
Hcs24, but not the synthetic peptide of the corresponding
region of Cyr61, inhibited the binding of the anti-CTGF/
Hcs24 antibodies to the 38 kDa CTGF/Hcs24 protein27.
After blocking with normal goat serum, polyclonal anti-
bodies against CTGF/Hcs24 was applied as primary
antibody for 2 h, and then incubated for 30 min with
biotinylated anti-rabbit antibody. After rinsing in PBS, speci-
mens were incubated with ABC reagent (Vectastain Elite
ABC Kit, Vector Laboratories, Burlingame, CA, USA), and
then washed with distilled water. The reaction was visual-
ized by diaminobenzidine (DAB) resulting in a brown color,
and counterstained with hematoxylin. Stained sections
incubated with normal non-immune rabbit immunoglobulin
(IgG) or without primary antibodies were used as negative
controls.
SEMI-QUANTITATIVE ANALYSIS FOR CTGF/HCS24-POSITIVE CELLS
Immunoreactivity was evaluated by light microscopy. The
chondrocytes with deﬁnite, diffusely stained cytoplasm or
nuclei were regarded as positively stained. The populations
of CTGF/Hcs24-positive cells in the superﬁcial, middle and
deep layers of OA cartilage, and in the ﬁbrocartilage,
proliferative, hypertrophic zones of chondro-osteophyte30
were quantiﬁed by counting the number of the cells within
the three layers and the three zones, respectively. Cell
number counting was done in at least 3 ﬁelds, at !100
magniﬁcation, and averaged. Judgment was based on the
consensus of at least two of the authors (SO and MS)
without reference to the patients’ clinical information. The
number of positive chondrocytes was divided by the total
number of chondrocytes within all 3 layers and 3 zones to
calculate the positive chondrocyte ratio. The marginal areas
between each layers and each zones were avoided for cell
counting to reduce the inter-observer errors. The frequency
levels of CTGF/Hcs24-positive cells were divided into six
groups: : 0%; G: 0e10%; C: 11e30%; CC: 31e50%;
CCC: 51e70%; CCCC: 71e100%.
IN SITU HYBRIDIZATION FOR CTGF/HCS24 MRNA
The parafﬁn sections were washed with PBS, reﬁxed with
1% paraformaldehyde, and treated with 2 mg/ml glyci-
neePBS. Then they were immersed in 0.1 M triethanola-
mineeHCl ( pH 8.0), after which acetic acid-anhydride was
added and the slides were rinsed twice with 4! standard
salineecitrate (SSC) for 10 min, and immersed in pre-
hybridization buffer (2! SSC, 50% formamide and 1 mM
levamisole) at 70(C for 15 min to decrease the intrinsic
alkaline phosphatase activity. In situ hybridization was
performed at 52(C using DIG-labeled sense and antisense
CTGF/Hcs24 riboprobes (0.35 mg/ml) as previously de-
scribed32. Sense and antisense RNA probes were synthe-
sized with T3 and T7 RNA polymerases from cDNA
templates of CTGF/Hcs24 cDNA (1.1 kb whole coding
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nostics Corp., Indianapolis, IN). After hybridization, the color
reaction was performed with 1:2000 dilution of 150 U/
200 mL anti-DIG alkaline phosphatase-conjugated antibody
(Roche), and nitroblue tetrazolium chloride (NBT) and 5-
bromo-4-chloro-3-indolyphosphate (BCIP) in an alkaline
buffer solution containing 1 mM levamisole in a dark room
at room temperature32.
Results
EXPRESSION OF CTGF/HCS24 PROTEIN IN OA CARTILAGE
CTGF/Hcs24-positive chondrocytes were expressed in
a small population of chondrocytes throughout the layers of
cartilage with morphologically normal structure [Fig. 1(aed)].
In early stage OA cartilage (1e3 points), the population of
immuno-positive chondrocytes in the superﬁcial layer
(51e70%) was higher than those in middle (11e30%) and
deep (0e10%) layers [Fig. 1(eeh)]. In moderate OA
cartilage (4e8 points), the superﬁcial layer was much
reduced or destroyed, and ﬁbrillated. Immuno-localization
of CTGF/Hcs24 was observed in individual and clustering
chondrocytes in the middle (51e70%) and deep (31e50%)
layers [Fig. 1(iek)]. In severe OA cartilage (9e13 points), the
superﬁcial layer and a part of the middle layer had
disappeared, and chondrocytes in the middle (71e100%)
and deep (51e70%) layers showed signiﬁcant reaction for
CTGF/Hcs24 [Fig. 1(len)]. The vascular endothelial cells
and periosteal osteoblastic cells also showed a weak to
moderate signal for CTGF/Hcs24, which was similar to that
previously reported by Nakata et al.33. No positive immuno-
reaction was seen in the control specimens. Results of semi-
quantitative analysis for CTGF/Hcs24-positive cells in OA
cartilage are summarized in Table I .The in situ hybridization
analysis conﬁrmed the expression of CTGF/Hcs24 by OA
chondrocytes at the mRNA level, and the distribution of
positive chondrocytes was similar to that of CTGF/Hcs24
immuno-positive chondrocytes (Fig. 2).
EXPRESSION OF CTGF/HCS24 PROTEIN IN CHONDRO-OSTEOPHYTE
Chondrocytes forming chondro-osteophyte also showed
positive reaction for CTGF/Hcs24. A weak staining for
CTGF/Hcs24 was observed in the chondrocytes of the
ﬁbrocartilage zone (0e10%), and a strong signal was
detected in the chondrocytes of the proliferative (11e30%)
and hypertrophic (31e50%) zones. The endothelial cells and
osteoblastic cells in the calciﬁed zone also showed a weak to
moderate signal for CTGF/Hcs24 [Fig. 3(A, B)]. Results of
semi-quantitative analysis for CTGF/Hcs24-positive cells in
chondro-osteophyte are summarized in Table I. In situ
hybridization showed signiﬁcant expression of CTGF/Hcs24
mRNA by proliferating and hypertrophic chondrocytes within
chondro-osteophyte [Fig. 3(D, E)]. No positive signal was
detected in specimens used for speciﬁcity of immunohisto-
chemistry and in situ hybridization [Fig. 3(C, F)].
Discussion
Kumar et al.29 ﬁrst demonstrated that CTGF/Hcs24 was
one of the top 20 most abundant genes expressed in both
normal (seventeenth) and OA (sixth) cartilage libraries. The
result of expressed sequenced tags (ESTs) was further
conﬁrmed by Northern blot analysis showing that CTGF/
Hcs24 was detected in two of four control samples andthree of four OA cartilage samples. In the present study, we
demonstrated the expression and localization of CTGF/
Hcs24 in the normal and OA joint at protein and mRNA
levels. The expression of CTGF/Hcs24 was seen in
chondrocytes in all layers of normal cartilage, and up-
regulated in chondrocytes in OA cartilage, as well as in the
proliferative and hypertrophic zones of chondro-osteophyte.
The early structural changes of OA are characterized by
a conspicuous increase in chondrocyte numbers. A re-
markable process of proliferation of the cells remaining
between the ﬁbrillary clefts begins, and this alteration
parallels the increased synthesis of macromolecules
characteristic of the early disease. Although the mechanism
of chondrocyte proliferation is poorly understood, a potential
role for growth factors, such as TGF-b, IGF-1, BMP, FGFs
has been assumed34. It was reported that recombinant
CTGF/Hcs24 protein (20e50 ng/ml) promotes the prolifer-
ation of chondrosarcoma cells (HCS-2/8) and rabbit growth
cartilage cells in sparse and growing cultures35. In addition,
CTGF/Hcs24 increases the proteoglycan synthesis and
gene expressions of aggrecan and collagen type II, typical
markers of chondrocyte maturation in both types of cells
in conﬂuent cultures where they were maturing20. Interest-
ingly, the phenotype of CTGF/Hcs24 mutant showed that
CTGF/Hcs24 is required for chondrocyte proliferation and
enchondral ossiﬁcation36. These results suggest that
chondrocyte differentiation and hypertrophy in the course
of cartilage alteration may stimulate the production of
CTGF/Hcs24, which can act as an autocrine and paracrine
growth factor to further promote the proliferation and
differentiation of the cells. CTGF/Hcs24 may also play a role
in production of extracellular matrix molecules such as type
I and type II collagen, or production of proteoglycans by
chondrocytes, as a part of the attempt to repair.
Previous studies indicated that the gene expression of
CTGF/Hcs24 is up-regulated in various ﬁbrous disorders.
CTGF/Hcs24 was shown to promote the proliferation and
migration of ﬁbroblasts in vitro, and induce expression of
extracellular molecules, including type I collagen, ﬁbronec-
tin, and a5 integrin37. Recently, we have shown that the
expression of CTGF/Hcs24, especially in proliferative and
hypertrophic chondrocytes, is increased at mRNA and
protein levels at sites of cartilage regeneration during
fracture healing in mouse ribs33. These facts suggest that
the expression of CTGF/H24 by cloning chondrocytes in OA
cartilage exposed to the synovial ﬂuid might be linked with
the development of the ﬁbrous tissue over the damaged
cartilage.
Pfander et al.38 reported vascular endothelial growth
factor (VEGF) mRNA and protein expression in OA cartilage.
They found a signiﬁcant increase of VEGF immuno-positive
chondrocytes in severe OA cartilage compared with normal
articular cartilage. Enlarged chondrocytes clustered next to
the cartilage surface showed strong immuno-reaction for
VEGF, which is consistent with the localization of CTGF/
Hcs24 in the current study (Fig. 1). As VEGF and CTGF/
Hcs24 are down-stream effectors of TGF-b, an interaction
between VEGF and CTGF/Hcs24 in OA cartilage can be
speculated. Inoki et al.39 reported that CTGF/Hcs24 inhibits
VEGF165-induced angiogenesis by forming a complex of the
two growth factors. It is also reasonable to speculate that
increased expression of CTGF/Hcs24 by OA chondrocytes
might have roles in the promotion of ﬁbrosis in damaged
cartilage, and in the regulation of VEGF function.
In the current study, we also showed that CTGF/Hcs24 is
expressed by hypertrophic chondrocytes of chondro-osteo-
phyte. The histological appearance of chondro-osteophyte
774 S. Omoto et al.: CTGF/Hcs24/CCN2 in OAFig. 1. Expression and localization of CTGF/Hcs24 in morphologically normal cartilage and early, moderate and severe stage OA cartilage
detected by immunohistochemistry (IHC). Signals for CTGF/Hcs24 protein were distributed in chondrocytes throughout the layers of normal
cartilage (aed). In early stage OA, the expression of CTGF/Hcs24 was up-regulated mainly at the superﬁcial layer of early stage OA cartilage
(eeh; arrows). In moderate and severe OA cartilage, superﬁcial zone cartilage was much reduced, and immuno-localization of CTGF/Hcs24
was observed in individual and clustering chondrocytes in the middle and deep cartilage layers (ien; arrows). (Original magniﬁcation; a, e, i,
l: !50, bed, feh, j, k, m, n: !100.) S, superﬁcial layer (b, f); M, middle layer (c, g, j, m); D, deep layer (d, h, k, n).resembles normal enchondral ossiﬁcation at the epiphyseal
plate30. Ivkovic et al.36 reported that CTGF/Hcs24 de-
ﬁciency leads to skeletal dysmorphisms as a result of
impaired chondrocyte proliferation and extracellular matrix
composition within the hypertrophic zone of the growth plate
cartilage. Interestingly, a mutation in WISP3, a member of
CCN family, is associated with the autosomal recessive
skeletal disorder progressive pseudorheumatoid dysplasia,
which clinically shows continued cartilage loss and bone
destruction40. The data of the current study support the ideathat expression of CTGF/Hcs24 chondrocytes in prolifera-
tive and hypertrophic zones of chondro-osteophyte contrib-
utes to chondrocyte proliferation, differentiation, and cell
death as well as the penetration of blood cells into calcifying
cartilage from bone marrow. Moreover, TGF-b has been
shown to be highly expressed in the hypertrophic chon-
drocytes of chondro-osteophyte41, the predominant expres-
sion of CTGF/Hcs24 in the proliferative and hypertrophic
chondrocytes in chondro-osteophyte may be related to the
high level of TGF-b.
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Summary of semi-quantitative analysis for CTGF/Hcs24-positive chondrocytes in OA cartilage and chondro-osteophyte
OA stage Modiﬁed Mankin score Cartilage layer
Superﬁcial Middle Deep
Normal (0) C G G
Early (1e3) CCC C G
Moderate (4e8) * CCC CC
Severe (9e13) * CCCC CCC
Chondro-osteophyte Zone
Fibrocartilage Proliferative Hypertrophic
G C CC
Positive cell ratios labeled by anti-CTGF/Hcs24 antibody were expressed: e: 0%,G: 0e10%,C: 11e30%,CC: 31e50%,CCC: 51e70%,
CCCC: 71e100% of cells positive.
*: Superﬁcial zone was already destroyed.
Fig. 2. Expression and localization of CTGF/Hcs24 detected by in situ hybridization (ISH). Expression of mRNA of CTGF/Hcs24 was identiﬁed
throughout the layer of normal cartilage (a), especially in the superﬁcial layer (a; arrows), and observed in the superﬁcial and middle layer of
early stage OA cartilage (b; arrows). In moderate and severe stage, CTGF/Hcs24 mRNA was expressed in the middle and deep layer
chondrocytes, especially in the cloned chondrocytes (c, d; arrows). (Original magniﬁcation; aed:! 50, in insets:! 200.) S, superﬁcial layer;
M, middle layer; D, deep layer.
776 S. Omoto et al.: CTGF/Hcs24/CCN2 in OAFig. 3. Expression and localization of CTGF/Hcs24 at protein and mRNA levels were detected in proliferating and hypertrophic chondrocytes
which form the chondro-osteophyte by immunohistochemistry (IHC) (A, B; arrows) and in situ hybridization (ISH) (D, E; arrows), respectively.
Negative controls for IHC obtained by excluding the primary antibody, and negative controls for ISH using the sense human CTGF/Hcs24 RNA
probe are shown in C and F, respectively. (Original magniﬁcation; A, D:!50, B, C, E, F:!200.) f, ﬁbrocartilage zone; p, proliferative zone; h,
hypertrophic zone; c, calciﬁed zone.In conclusion, CTGF/Hcs24 is expressed by normal and
OA chondrocytes at the mRNA and protein levels. A strong
positive immuno-reaction for CTGF/Hcs24 was seen in the
clustering chondrocytes next to the damaged cartilage
surface, as well as in proliferating and hypertrophic
chondrocytes in chondro-osteophyte, suggesting the ex-
pression of CTGF/Hcs24 appeared to be related to cartilage
degeneration and chondrocyte differentiation. The results of
the current study may contribute to understanding of the
anabolic activity of chondrocytes in the course of cartilage
destruction of OA.Acknowledgements
The authors wish to thank Ms. Cherie McCown for
assistance in editing drafts of the manuscript.
References
1. Gardner DL. Osteoarthrosis and allied diseases. In:
Pathological Basis of the Connective Tissue Dis-
eases. London: Edward Arnold 1992;842e923.
777Osteoarthritis and Cartilage Vol. 12, No. 102. Lajeunesse D, Massicotte F, Pelletier JP, Martel-
Pelletier J. Subchondral bone sclerosis in osteoarth-
ritis: not just an innocent bystander. Mod Rheumatol
2003;13:7e14.
3. Poole AR, Howell DS. Etiopathogenesis of osteoarthri-
tis. In: Moskowitz RW, Howell DS, Altman RD,
Buckwalter JA, Goldberg VM, Eds. Osteoarthritis:
Diagnosis and Medical/Surgical Management.
Philadelphia: W.B. Saunders Company 2001;29e47.
4. Tyler JA, Hunziker EB. Articular cartilage regeneration.
In: Brandt KD, Doherty M, Lohmander LS, Eds.
Osteoarthritis. Oxford: Oxford University Press 1998;
94e108.
5. Twal WO, Vasilatos-Younken R, Gay CV, Leach RM Jr.
Isolation and localization of basic ﬁbroblast growth
factor-immunoreactive substance in the epiphyseal
growth plate. J Bone Miner Res 1994;9:1737e44.
6. Jakob M, Demarteau O, Schafer D, Hintermann B, Dick
W, Heberer M, et al. Speciﬁc growth factors during the
expansion and redifferentiation of adult human artic-
ular chondrocytes enhance chondrogenesis and
cartilaginous tissue formation in vitro. J Cell Biochem
2001;81:368e77.
7. Ribault D, Khatib AM, Panasyuk A, Barbara A, Bouizar
Z, Mitrovic RD. Mitogenic and metabolic actions of
epidermal growth factor on rat articular chondrocytes:
modulation by fetal calf serum, transforming growth
factor-beta, and tyrphostin. Arch Biochem Biophys
1997;337:149e58.
8. Bonassar LJ, Trippel SB. Interaction of epidermal
growth factor and insulin-like growth factor-I in the
regulation of growth plate chondrocytes. Exp Cell Res
1997;234:1e6.
9. Morales TI, Hunziker EB. Localization of insulin-like
growth factor binding protein-2 in chondrocytes of
bovine articular cartilage. J Orthop Res 2003;21:
290e5.
10. Ellingsworth LR, Brennan JE, Fok K, Rosen DM, Bentz
H, Piez KA, et al. Antibodies to the N-terminal portion
of cartilage-inducing factor A and transforming growth
factor beta. Immunohistochemical localization and
association with differentiating cells. J Biol Chem
1986;261:12362e7.
11. Fukui N, Zhu Y, Maloney WJ, Clohisy J, Sandell LJ.
Stimulation of BMP-2 expression by pro-inﬂammatory
cytokines IL-1 and TNF-alpha in normal and osteoar-
thritic chondrocytes. J Bone Joint Surg Am 2003;85:
59e66.
12. Nakase T, Miyaji T, Tomita T, Kaneko M, Kuriyama K,
Myoui A, et al. Localization of bone morphogenetic
protein-2 in human osteoarthritic cartilage and osteo-
phyte. Osteoarthritis Cartilage 2003;11:278e84.
13. Bobacz K, Gruber R, Soleiman A, Erlacher L, Smolen
JS, Graninger WB. Expression of bone morpho-
genetic protein-6 in healthy and osteoarthritic human
articular chondrocytes and stimulation of matrix
synthesis in vitro. Arthritis Rheum 2003;48:2501e8.
14. Nakanishi T, Kimura Y, Tamura T, Ichikawa H, Yamaai
Y, Sugimoto T, et al. Cloning of a mRNA preferentially
expressed in chondrocytes by differential display-PCR
from a human chondrocytic cell line that is identical
with connective tissue growth factor (CTGF) mRNA.
Biochem Biophys Res Commun 1997;234:206e10.
15. Takigawa M, Tajima K, Pan HO, Enomoto M, Kinoshita
A, Suzuki F, et al. Establishment of a clonal human
chondrosarcoma cell line with cartilage phenotypes.
Cancer Res 1989;49:3996e4002.16. Takigawa M, Pan HO, Kinoshita A, Tajima K, Takano
Y. Establishment from a human chondrosarcoma
of a new immortal cell line with high tumorigenicity
in vivo, which is able to form proteoglycan-rich
cartilage-like nodules and to respond to insulin
in vitro. Int J Cancer 1991;48:717e25.
17. Zhu JD, Pan HO, Suzuki F, Takigawa M. Proto-onco-
gene expression in a human chondrosarcoma cell
line: HCS-2/8. Jpn J Cancer Res 1994;85:364e71.
18. Tuckwell DS, Ayad S, Grant ME, Takigawa M,
Humphries MJ. Conformation dependence of integ-
rin-type II collagen binding. Inability of collagen
peptides to support alpha 2 beta 1 binding, and
mediation of adhesion to denatured collagen by
a novel alpha 5 beta 1-ﬁbronectin bridge. J Cell Sci
1994;107:993e1005.
19. Ohba Y, Goto Y, Kimura Y, Suzuki F, Hisa T,
Takahashi K, et al. Puriﬁcation of an angiogenesis
inhibitor from culture medium conditioned by a human
chondrosarcoma-derived chondrocytic cell line,
HCS-2/8. Biochim Biophys Acta 1995;1245:1e8.
20. Takigawa M, Nakanishi T, Kubota S, Nishida T. Role of
CTGF/Hcs24/ecogenin in skeletal growth control.
J Cell Physiol 2003;194:256e66.
21. Bork P. The modular architecture of a new family of
growth regulators related to connective tissue growth
factor. FEBS Lett 1993;327:125e30.
22. Bradham DM, Igarashi A, Potter RL, Grotendorst GR.
Connective tissue growth factor: a cysteine-rich mito-
gen secreted by human vascular endothelial cells is
related to the SRC-induced immediate early gene
product CEF-10. J Cell Biol 1991;114:1285e94.
23. Igarashi A, Okochi H, Bradham DM, Grotendorst GR.
Regulation of connective tissue growth factor gene
expression in human skin ﬁbroblasts and during
wound repair. Mol Biol Cell 1993;4:637e45.
24. Oemar BS, Luscher TF. Connective tissue growth
factor: friend or foe? Arterioscler Thromb Vasc Biol
1997;17:1483e9.
25. Nishida T, Nakanishi T, Shimo T, Asano M, Hattori T,
Tamatani T, et al. Demonstration of receptors speciﬁc
for connective tissue growth factor on a human
chondrocytic cell line (HCS-2/8). Biochem Biophys
Res Commun 1998;247:905e9.
26. Nishida T, Nakanishi T, Asano M, Shimo T, Takigawa
M. Effects of CTGF/Hcs24, a hypertrophic chondro-
cyte-speciﬁc gene product, on the proliferation and
differentiation of osteoblastic cells in vitro. J Cell
Physiol 2000;184:197e206.
27. Shimo T, Nakanishi T, Nishida T, Asano M, Kanyama
M, Kuboki T, et al. Connective tissue growth factor
induces the proliferation, migration, and tube forma-
tion of vascular endothelial cells in vitro, and
angiogenesis in vivo. J Biochem (Tokyo) 1999;126:
137e45.
28. Shimo T, Nakanishi T, Kimura Y, Nishida T, Ishizeki K,
Matsumura T, et al. Inhibition of endogenous expres-
sion of connective tissue growth factor by its
antisense oligonucleotide and antisense RNA sup-
presses proliferation and migration of vascular endo-
thelial cells. J Biochem (Tokyo) 1998;124:130e40.
29. Kumar S, Connor JR, Dodds RA, Halsey W, Van Horn
M, Mao J, et al. Identiﬁcation and initial characteriza-
tion of 5000 expressed sequenced tags (ESTs) each
from adult human normal and osteoarthritic cartilage
cDNA libraries. Osteoarthritis Cartilage 2001;9:
641e53.
778 S. Omoto et al.: CTGF/Hcs24/CCN2 in OA30. Nishida K, Doi T, Matsuo M, Ishiwari Y, Tsujigiwa H,
Yoshida A, et al. Involvement of nitric oxide in
chondrocyte cell death in chondro-osteophyte forma-
tion. Osteoarthritis Cartilage 2001;9:232e7.
31. van der Sluijs JA, Geesink RG, van der Linden AJ,
Bulstra SK, Kuyer R, Drukker J. The reliability of the
Mankin score for osteoarthritis. J Orthop Res 1992;10:
58e61.
32. Meyer D, Yamaai T, Garratt A, Riethmacher-
Sonnenberg E, Kane D, Theill LE, et al. Isoform-
speciﬁc expression and function of neuregulin.
Development 1997;124:3575e86.
33. Nakata E, Nakanishi T, Kawai A, Asaumi K, Yamaai T,
Asano M, et al. Expression of connective tissue
growth factor/hypertrophic chondrocyte-speciﬁc gene
product 24 (CTGF/Hcs24) during fracture healing.
Bone 2002;31:441e7.
34. Rosier RN, Reynolds PR, O’Keefe RJ. Molecular and
cell biology in orthopaedics. In: Buckwalter JA,
Einhorn TA, Simon SR, Eds. Orthopaedic Basic
Science: Biology and Biomechanics of the Musculo-
skeletal System. Illinois: American Academy of
Orthopaedic Surgeons 2000;19e76.
35. Nakanishi T, Nishida T, Shimo T, Kobayashi K, Kubo T,
Tamatani T, et al. Effects of CTGF/Hcs24, a product
of a hypertrophic chondrocyte-speciﬁc gene, on the
proliferation and differentiation of chondrocytes in
culture. Endocrinology 2000;141:264e73.36. Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE,
Stephenson RC, et al. Connective tissue growth
factor coordinates chondrogenesis and angiogenesis
during skeletal development. Development 2003;130:
2779e91.
37. Frazier K, Williams S, Kothapalli D, Klapper H,
Grotendorst GR. Stimulation of ﬁbroblast cell growth,
matrix production, and granulation tissue formation by
connective tissue growth factor. J Invest Dermatol
1996;107:404e11.
38. Pfander D, Kortje D, Zimmermann R,Weseloh G, Kirsch
T, Gesslein M, et al. Vascular endothelial growth factor
in articular cartilage of healthy andosteoarthritic human
knee joints. Ann Rheum Dis 2001;60:1070e3.
39. Inoki I, Shiomi T, Hashimoto G, Enomoto H, Nakamura
H, Makino K, et al. Connective tissue growth factor
binds vascular endothelial growth factor (VEGF) and
inhibits VEGF-induced angiogenesis. FASEB J 2002;
16:219e21.
40. Hurvitz JR, Suwairi WM, Van Hul W, El-Shanti H,
Superti-Furga A, Roudier J, et al. Mutations in the CCN
gene family member WISP3 cause progressive pseu-
dorheumatoid dysplasia. Nat Genet 1999;23:94e8.
41. van Beuningen HM, van der Kraan PM, Arntz OJ, van
den Berg WB. Transforming growth factor-beta 1
stimulates articular chondrocyte proteoglycan synthe-
sis and induces osteophyte formation in the murine
knee joint. Lab Invest 1994;71:279e90.
